WuXi AppTec (WUXAY) Expected to Post Earnings on Monday

WuXi AppTec (OTCMKTS:WUXAY) is expected to announce its resultson Monday, July 27th. Analysts expect WuXi AppTec to post earnings of $0.2321 per share and revenue of $1.9111 billion for the quarter.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Price Performance

WUXAY opened at $20.05 on Friday. The stock’s 50 day moving average price is $17.69 and its 200-day moving average price is $16.10. WuXi AppTec has a 52-week low of $12.45 and a 52-week high of $21.35.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.